Copyright
©The Author(s) 2018.
World J Stem Cells. May 26, 2018; 10(5): 43-56
Published online May 26, 2018. doi: 10.4252/wjsc.v10.i5.43
Published online May 26, 2018. doi: 10.4252/wjsc.v10.i5.43
Composition | Type | Advantages | Disadvantages | Payload | Homing to | Ref. |
Polymeric NP | Poly(D,L-lactide), poly(D,L-lactic acid-co-α,β-malic acid),Poly-L-lactic acid | Biocompatible, FDA approved, versatility, efficient upload by stem cells, human HSCs, MSCs retain differentiation potential | Biphasic and uncontrolled payload release | Antitumour drugs, | Glioma tumours | [77-79] |
Silica NP | Mesoporous silica, amorphous silica | Fast uptake, negligible toxicity, long retention inside cells, lysosomal activation not associated with oxidative stress | Long term remanence within cells/tissues | Antitumour drug doxorubicin, fluorescent dye, paclitaxel | Mammary tumours, infarcted heart | [80-82,92] |
Liposomal NP | Liposomes | Relatively facile manufacturing, versatility for drug delivery | Less-efficient uptake process, higher concentrations needed, which can be toxic to cells | 6-coumarin | Glioma tumours | [83] |
Magnetic nanoparticles | Iron oxide NPs, magnetite, maghemite | Cellular tracking potential, reduced cell toxicity, high loading efficiency | Can induce oxidative stress in carrier cells | NGF, FGF | Dorsal root ganglia, HUVECs | [84-86] |
- Citation: Labusca L, Herea DD, Mashayekhi K. Stem cells as delivery vehicles for regenerative medicine-challenges and perspectives. World J Stem Cells 2018; 10(5): 43-56
- URL: https://www.wjgnet.com/1948-0210/full/v10/i5/43.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v10.i5.43